iStock
White Paper

Understanding MRD and MCED Research Approaches

Explore the purpose, methods, and research impact of minimal residual disease assessment and multi-cancer early detection in precision oncology

Brought to you byIntegrated DNA Technologies

Researchers are studying cancer-associated molecular signals to advance research in cancer characterization, surveillance, and detection. Two leading approaches are minimal residual disease (MRD) assessment, which examines signals that may persist following treatment, and multi-cancer early detection (MCED) research, which investigates signals across multiple cancer types. In both, the signals of interest are often rare and evade detection by standard laboratory techniques, requiring highly sensitive analytical methods.

This resource provides an overview of MRD and MCED research, including the molecular approaches used in each and the considerations involved. These insights can help laboratory professionals identify the workflow requirements and trade-offs to consider when developing or evaluating MRD and MCED research workflows. 

Download this research guide to:

  • Understand the research applications and impact of MRD and MCED
  • Review how molecular signals are assessed within each area
  • Compare tumor-informed and tumor-naïve approaches to MRD assessment
  • Examine sample and analytical considerations for sensitive sequencing workflows

For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.

Sponsored by

  • Integrated DNA Technologies logo